Articles From: Valley National Bancorp Completes Its Merger Of 1st United Bancorp, Inc. to Antares Pharma Announces Last Patient Enrolled in Phase 3 QuickShot® Study Evaluating Testosterone-Deficient Adult Males


WAYNE, N.J. , Nov.
Sign-up for Valley National Bancorp Completes Its Merger Of 1st United Bancorp, Inc. investment picks
NEW YORK, Nov.
Sign-up for NeoStem to Present at Multiple Conferences This Week investment picks
The Board of Directors of AmerisourceBergen Corporation (NYSE: ABC) today increased the Company’s quarterly dividend rate 23 percent to $0.29 per common share from $0.235 per common share.
Sign-up for AmerisourceBergen Increases Dividend 23 Percent investment picks
TransAct Technologies Incorporated (Nasdaq: TACT), a global leader in market-specific solutions, including printers, terminals, software and other products for transaction-based and other industries, announced today that its Board of Directors declared a quarterly cash dividend of $0.08 per share and also approved a modification to the current stock repurchase return of capital program.
Sign-up for TransAct Technologies Declares Quarterly Cash Dividend of $0.08 Per Share investment picks
Firm Adds Specialized Industry Expertise and Petroleum Engineering Skills WASHINGTON , Nov.
Sign-up for FTI Consulting Enhances Oil and Gas Practice investment picks
Kenneth Kopp will lead company's direct response division OWINGS MILLS, Md.
Sign-up for Medifast Appoints Vice President, Medifast Direct investment picks
MALVERN, Pa., Nov.
Sign-up for TetraLogic Pharmaceuticals to Host Investor Forum on November 10, 2014 investment picks
Ophthotech Corporation (Nasdaq:OPHT) today announced that it will release its financial results for the third quarter ended September 30, 2014, on Tuesday, November 11, 2014.
Sign-up for Ophthotech Corporation to Announce Third Quarter 2014 Financial Results and Host Conference Call on Tuesday, November 11, 2014 investment picks
Agilysys, Inc .
Sign-up for Harbor Winds Hotel Implements rGuest™ Stay by Agilysys investment picks
MIDLAND, Mich., Nov.
Sign-up for Chemical Financial Corporation to Partner With Monarch Community Bancorp, Inc. investment picks
NEW YORK (MarketWatch) -- American Realty Capital Properties' stock (ARCP) tumbled 13% in premarket trade Monday, after RCS Capital said it terminated its agreement to buy American Realty's Cole Capital business.
Sign-up for American Realty's stock tumbles after Cole Capital sale deal terminated investment picks
GREENVILLE, S.C. , Nov.
Sign-up for KEMET Corporation Announces Proposed Private Offering Of Senior Secured Notes Due 2019 investment picks
MIDDLETOWN, R.I., Nov.
Sign-up for KVH Receives $4.3 Million Order for Military Navigation Systems investment picks
SALT LAKE CITY, Nov.
Sign-up for Myriad and AbbVie Sign Expanded Agreement for Tumor BRACAnalysis CDx(TM) investment picks
MRV Communications™, Inc. (NASDAQ:MRVC), a global provider in converged packet and optical solutions that empower the optical edge and network integration services for communications service providers, will host a conference call at 5:00 p.m. ET on Wednesday, November 5, 2014 to discuss its third quarter 2014 earnings results.
Sign-up for MRV to Discuss Third Quarter 2014 Results investment picks
Sally Beauty Holdings, Inc. (NYSE: SBH) today announced the retirement of Martha J.
Sign-up for Sally Beauty Holdings, Inc. Announces the Retirement of Martha J. Miller from its Board of Directors and the Appointment of Susan R. Mulder to the Board of Directors investment picks
SAN DIEGO, Calif., Nov.
Sign-up for Cubic Integrates oti's WAVE NFC Device Into Its NextWave Mobile Mass Transit Platform investment picks
Kosmos Energy Ltd.
Sign-up for Kosmos Energy Announces Third Quarter 2014 Results investment picks
Conference Call and Webcast to Follow THE WOODLANDS, Texas , Nov.
Sign-up for Lexicon To Report Third Quarter 2014 Financial Results On November 4, 2014 investment picks
SOUTH SAN FRANCISCO, Calif., Nov.
Sign-up for Sunesis to Host Conference Call on November 10th to Discuss Third Quarter 2014 Financial Results and Recent Highlights investment picks
Antares Pharma, Inc. (NASDAQ: ATRS) today announced that the last patient has been enrolled in a double-blind, multiple-dose, phase 3 study to evaluate the efficacy and safety of QuickShot ® Testosterone (QS T) administered subcutaneously once each week to testosterone-deficient adult males.
Sign-up for Antares Pharma Announces Last Patient Enrolled in Phase 3 QuickShot® Study Evaluating Testosterone-Deficient Adult Males investment picks
Start Premium Trial Register For Free

P F Fund Financial Data (13,000+ funds)
P F Stock Financial Data (7,000+ stocks)
P F Stock and Fund Screeners (basic)
P F Investing Articles and Market Commentary
P F Articles Archive (>30 days)
P F Discuss (dozens of stock, fund, bond, and general bulletin boards)
P F Portfolio Manager (basic)
P F Morningstar Investment Classroom
P F Access Your Portfolio Anytime, Anywhere via Your Mobile Device
P   Morningstar Fund Analyst Reports (full research on 1,700 funds, ETFs, and CEFs)
P   Morningstar Stock Analyst Reports (full research on more than 1,100 stocks)
P   Portfolio Manager (advanced with 10 X-Ray analyses, including recommendations)
P   Portfolio Monitor (monthly and on-demand personalized portfolio statements)
P   Morningstar Proprietary Stock Information (stock star ratings, buy/sell prices, economic moat ratings, and more)
P   Morningstar 5-Star Stock and Fund Favorites & Red Flags eNewsletters
P   Premium Stock and Fund Screeners (advanced with nearly infinite ways to find the best securities for you)
P   Discounts on Morningstar newsletters, books, seminars, and more

Sign-up to Morningstar


Basic Access

Articles and Videos
Morningstar video reports, articles, data, and tools. Dig into our lineup of e-newsletters and investing classroom courses outlining sensible strategies for maximizing your investments.
Morningstar Discuss
Follow the buzz on individual stocks or fund families. Plus, read the latest posts from Morningstar members and analysts.
Portfolio Manager
Track your investments and watch lists with our Portfolio Manager. Customize your view with our comprehensive stock, fund, and ETF data.

Access these features and more when you sign up for Free Membership.
Join Morningstar today. It's Free.

Unlimited Access

Analyst Research
Gather in-depth, actionable insight on over 3,700 stock and mutual funds covered by Morningstar analysts. View our mutual fund Analyst Reports favored by professionals, savvy experienced investors, and new investors researching options for retirement savings, college plans, or other investment needs.
Portfolio X-Ray®
Ensure your portfolio is positioned exactly how you want with Morningstar's X-Ray Interpreter and Stock Intersection tools. A Barron's "Best of the Web" award winner for five years running, X-Ray Interpreter goes under the hood of your portfolio to provide a useful allocation, sector, and geographic analysis. And you can discover how much of a stock you really own, individually and through mutual funds, with Stock Intersection.
Investment Picks
Find new 5-star stocks (greatly undervalued companies) to consider daily. Our 5-star stock rating is a proven winner, consistently beating benchmarks like the S&P 500. Plus, browse our Fund Analyst Picks and Stewardship Grades to find shareholder-friendly mutual funds that are poised for outperformance.
Portfolio Monitor
Get a clear view of your investments with personalized reports about your portfolio. Receive monthly statements and generate reports on-demand to help you stay on track to meet your investment goals.

Access these features and more when you sign up for Premium Membership.
Start your free 14-day trial today online
Your subscription may be tax deductible. Please contact your tax advisor.

Articles From: Valley National Bancorp Completes Its Merger Of 1st United Bancorp, Inc. to Antares Pharma Announces Last Patient Enrolled in Phase 3 QuickShot® Study Evaluating Testosterone-Deficient Adult Males
Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol |  Title Star Rating |  Category |  Total Assets |  Top Holdings |  Top Sectors |  Symbol |  Name Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol / Ticker |  Title Star Rating |  Category |  Total Assets |  Symbol / Ticker |  Name Title |  Date |  Author |  Collection |  Popularity |  Interest Title |  Date |  Company |  Symbol |  Interest |  Popularity Title |  Date |  Company |  Symbol |  Interest |  Popularity Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Popularity |  Our Choices |  Most Recent